SCHEMBL20738425

SCHEMBL20738425

C=C1C[C@@]23CC[C@@H]4[C@](C)(CO)CCC[C@@]4(C)[C@@H]2CC[C@@H]1C3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 1.00
HSD11B2 P80365 1/20 1.00
PTPN1 P18031 2/20 0.70
BCHE P06276 3/20 0.62
ACHE P22303 2/20 0.62
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR1H3 Q13133 1/20 0.42
CDC25B P30305 3/20 0.39
CDC25A P30304 2/20 0.39
F10 P00742 1/20 0.37
PTPN2 P17706 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
PAX8 Q06710 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401471 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL31238461 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL3491665 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL3491660 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL13401488 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL12450203 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL267551 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL31237650 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL21331728 1.00 HSD11B1 (1.00) HSD11B1HSD11B2PTPN1BCHEACHE
SCHEMBL21900813 0.85 HSD11B1 (0.74) HSD11B1HSD11B2PTPN1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371892-A1 STEVIA REBAUDIANA KAURENOIC ACID HYDROXYLASE VARIANTS FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES EUAGORE, LLC 2021-12-02 US disclosed
US-20200088698-A1 METHOD FOR DETERMINING WHETHER OR NOT INFECTION WITH BURSAPHELENCHUS XYLOPHILUS ECONNBIZ CO., LTD. (KR) 2020-03-19 US disclosed
WO-2019033064-A1 PISUM SATIVUM KAURENE OXIDASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES Amyris, Inc. (US) 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371892-A1 STEVIA REBAUDIANA KAURENOIC ACID HYDROXYLASE VARIANTS FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES SPR, ME1, ADH7 HSD11B1 100/4885HSD11B2 57/4885PTPN1 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.